-
Life Sciences BC – New Canadian Partner for Venture Valuation/Biotechgate
Zurich/Vancouver January 2018 Biotechgate/Venture Valuation announce entering a partnership with Life Sciences British Columbia, a … Read more
-
RESI Conference January 2018 – Deal and Product Valuations
RESI Conference, San Francisco January 2018, 36 pages Deal and Product Valuations
-
RESI Conference November 2017- Deal and Product Valuations
RESI Conference, New York November 2017, 37 pages Deal and Product Valuations
-
BIO IP & Diagnostics Symposium (IPDx) Keynote Session
Dr. Patrik Frei was the keynote speaker at BIO IP & Diagnostics Symposium (IPDx) on … Read more
-
Valuation Workshop at RESI Conference – Boston, September 2017
During the last RESI (Redefining Early Stage Investments) Conference – the event series organized by … Read more
-
Interviews with leading Life Sciences companies: PeptiDream Inc.
Inventiveness in peptide drug technology and a well thought- out business strategy characterize PeptiDream’s thriving … Read more
-
Assessing the Valuation of New Ventures – MassChallengeCH, Lausanne, September 2017
Venture Valuation CEO, Dr. Patrik Frei is one of the experts working as mentors for … Read more
-
Venture Valuations Biotechgate Collaborates with California Life Sciences Association (CLSA) to Connect California’s Life Sciences Sector
Zurich, Bay Area & San Diego, CA – August 2017 – California Life Sciences Association (CLSA), … Read more
-
Whitepaper: Focus on the Antibiotics Market
The antibiotics market is expected to reach USD 57.0 billion by 2024. Rising prevalence of … Read more
-
Valuation of Life Sciences Start-up – Questions and Answers
Last month, CEO of Venture Valuation, Dr Patrik Frei, delivered a live webinar titled ‘Valuation … Read more